Highly Sensitive Surface Plasmon Resonance Biosensor for the Detection of Urine Glucose Concentration

This paper analyzes a surface plasmon resonance (SPR) sensor utilizing silver (Ag) and Zirconium Nitride (ZrN) for glucose concentration detection in urine samples by the transfer matrix method (TMM). For effective SP excitation, a high-RI BAF10 prism is thought to be used as the coupling layer in the suggested theoretical design. The performance of the proposed SPR biosensor is theoretically evaluated using the wavelength interrogation technique by analyzing wavelength sensitivity (WS), detection accuracy (DA), figure of merit (FoM), and penetration depth (PD) parameters. Glucose in urine samples serves as the sensing medium (SM) in this biosensor configuration. The sensor achieves a maximum wavelength sensitivity of 6416.66 nm/RIU with a penetration depth of 297.53 nm. The ZrN structure incorporated in the biosensor demonstrates enhanced wavelength sensitivity through its molecular recognition sites that provide strong binding with glucose molecules. The improved wavelength sensitivity is attributed to the greater resonance wavelength shift produced by ZrN, resulting in significant performance enhancement of the biosensor for glucose detection. Benefits of the proposed SPR biosensor include very small urine sample concentration requirements (usually 0 mg/dL to 10 g/dL), compatibility with compact prism-based configurations that support the development of portable and affordable point-of-care devices, and quick detection within a few seconds due to real-time plasmonic response. These features make the sensor ideal for rapid, minimally invasive, and field-deployable glucose monitoring in both home and clinical relevance.